OR WAIT 15 SECS
December 11, 2020
Samit Hirawat, chief medical officer at Bristol Myers Squibb, talks about his leading role in BMS’ $300M, five-year plan to expand its efforts in health equity and his career-long commitment to putting patients first.
December 09, 2020
If telehealth is here to stay, how is the industry adjusting?
December 04, 2020
While patient support providers play an important role in keeping patients on therapy, biopharma companies have a great opportunity to push analytical sophistication beyond what many of these providers currently offer.
November 20, 2020
Oral solid dose formulations (OSD) continue to lead the market as a preferred dosage form. To gain better insight into drug dose delivery technology trends, Laura Child spoke to leaders from five top contract development and manufacturing organizations to find out what is on the horizon for patient-centric drug delivery.
November 19, 2020
Improving the patient experience for those with orphan diseases through a patient-first approach.
November 16, 2020
The importance of life sciences companies focused on rare diseases to take early steps to bridge connections with patients, caregivers, and healthcare providers.
November 03, 2020
Jo Fearnhead-Wymbs discusses how and why amplifying the patient voice is driving change in the industry for the better.
October 15, 2020
Therapeutic companies that work with rare diseases must take early steps to build relationships with patients, caregivers, and HCPs.
October 14, 2020
How ramped-up support and educational services have helped bridge the chasms and ease fears along the patient care continuum.
A look at best-practice approaches to aligning the strategy and design of hub service models with preparations for market entry of a new therapy.
